Protagonist Therapeutics, Inc Undrlyg Security Mkt Price Chng Pct
Protagonist Therapeutics, Inc (PTGX) had Undrlyg Security Mkt Price Chng Pct of 50.00% as of 2025-01-02, per its DEF 14A filed 2026-04-28.
Financial Statements › Notes
ecd:UndrlygSecurityMktPriceChngPct · last filed 2026-04-28
- 2025-01-02: Undrlyg Security Mkt Price Chng Pct 50.00%.
| Period end | Undrlyg Security Mkt Price Chng Pct |
|---|---|
| 2025-01-02 | 50.00% DEF 14A · filed 2026-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |